Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$70.00M
↑ 127% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-259.02M
Historical baseline
PeriodValueYoY Change
TTM$70.00M+145.3%
2024$-154.53M+68.8%
2023$-495.21M+19.8%
2022$-617.39M+15.6%
2021$-731.27M-134.2%
2020$-312.23M-4.5%
2019$-298.83M-
2018$0.00+100.0%
2017$-50.90M-32372.5%
2016$157710.00-